ALAS PROPIAS: BMGIM for Professionals Working in Intimate Partner Machista Violence Services (ALAS PROPIAS)

November 3, 2026 updated by: Eva Maria Leon Zarceño, Universidad Miguel Hernandez de Elche

ALAS PROPIAS Program. Music Therapy, Well-Being and Psychological Health in the Context of Machista Violence in Intimate Partner Relationships: A Triangulation Study

This study evaluates the impact of a 10-session individual music therapy intervention using the Bonny Method of Guided Imagery and Music (BMGIM) on the well-being and psychological health of professionals working in services supporting women experiencing intimate partner machista violence.

The study uses a controlled, non-randomized quasi-experimental design, with an experimental group and a wait-list control group. Changes in burnout, compassion fatigue, vicarious trauma, secondary traumatic stress, anxiety, positive and negative affect, emotional regulation, and professional well-being are assessed.

Study Overview

Status

Active, not recruiting

Detailed Description

Professionals working in services supporting women experiencing intimate partner machista violence may experience psychological consequences associated with continued exposure to others' traumatic experiences, including burnout, compassion fatigue, vicarious trauma, and secondary traumatic stress.

This study examines the impact of an individual music therapy intervention based on the Bonny Method of Guided Imagery and Music (BMGIM), consisting of 10 individual sessions. Using a controlled, non-randomized quasi-experimental design, outcomes in the experimental group are compared with those in a wait-list control group.

Changes in vicarious trauma and secondary traumatic stress, burnout, compassion fatigue, anxiety, positive and negative affect, emotional regulation, and professional well-being are assessed. The study aims to contribute scientific evidence on the potential of BMGIM music therapy to support the well-being and psychological health of professionals working in contexts of intimate partner machista violence.

Study Type

Interventional

Enrollment (Actual)

54

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Alicante
      • Elche, Alicante, Spain, 03202
        • Universidad Miguel Hernández de Elche

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Professionals working in centers or shelters supporting women experiencing intimate partner machista violence.
  • Direct professional contact with cases of intimate partner violence.
  • Interest in participating in the individual BMGIM intervention and provision of informed consent.

Exclusion Criteria:

  • Active psychosis.
  • Unstabilized suicidal crisis.
  • Uncontrolled substance use that prevents participation.
  • Inability to attend weekly sessions

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Individual BMGIM Music Therapy

Participants receive 10 individual music therapy sessions using the Bonny Method of Guided Imagery and Music (BMGIM).

The ALAS PROPIAS intervention consists of 10 individual music therapy sessions using the Bonny Method of Guided Imagery and Music (BMGIM), aimed at professionals working in services supporting women experiencing machista violence in intimate partner relationship. The intervention focuses on exploring imagery, emotions, and sensations through guided music listening, followed by a process of integration and reflection. The program aims to evaluate changes in burnout, compassion fatigue, vicarious trauma, secondary traumatic stress, anxiety, positive and negative affect, emotional regulation, psychological well-being, and professional well-being among participants.

No Intervention: Control Group (Wait-List)

Participants complete the same assessments as the experimental group during the initial study period but do not receive the intervention during this phase. The intervention may be offered after the initial data collection, in accordance with the study protocol.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Burnout
Time Frame: Baseline (T0), Immediate Post-intervention (T1), 3-month Follow-up (T2)

Burnout will be assessed using the Spanish adaptation of the Maslach Burnout Inventory (MBI) (Maslach & Jackson, 1981; Seisdedos, 1997). Scores at the final assessment will be compared with baseline scores to evaluate changes in burnout among participants in the experimental and wait-list control groups.

Baseline (T0), Immediate Post-intervention (T1), 3-month Follow-up (T2)
Change in Positive and Negative Affect
Time Frame: Baseline (T0), Immediate Post-intervention (T1), 3-month Follow-up (T2)

Positive and negative affect will be assessed using the Spanish adaptation of the Positive and Negative Affect Schedule (PANAS) (Sandín et al., 1999). Scores at the final assessment will be compared with baseline scores to evaluate changes in positive and negative affect in the experimental and wait-list control groups.

Baseline (T0), Immediate Post-intervention (T1), 3-month Follow-up (T2)
Change in Psychological Well-Being
Time Frame: Psychological well-being will be assessed using the Spanish adaptation of Ryff's Psychological Well-Being Scales (Díaz et al., 2006). Scores at the final assessment will be compared with baseline scores to evaluate changes in psychological well-being in

Psychological well-being will be assessed using the Spanish adaptation of Ryff's Psychological Well-Being Scales (Díaz et al., 2006). Scores at the final assessment will be compared with baseline scores to evaluate changes in psychological well-being in the experimental and wait-list control groups.

Psychological well-being will be assessed using the Spanish adaptation of Ryff's Psychological Well-Being Scales (Díaz et al., 2006). Scores at the final assessment will be compared with baseline scores to evaluate changes in psychological well-being in
Change in Professional Quality of Life
Time Frame: Baseline (T0), Immediate Post-intervention (T1), 3-month Follow-up (T2)

Professional quality of life will be assessed using the Spanish adaptation of the Professional Quality of Life Scale, version 5 (ProQOL-5) (Galiana et al., 2020). Scores at the final assessment will be compared with baseline scores to evaluate changes in professional quality of life in the experimental and wait-list control groups.

Baseline (T0), Immediate Post-intervention (T1), 3-month Follow-up (T2)
Change in Secondary Traumatic Stress
Time Frame: Baseline (T0), Immediate Post-intervention (T1), 3-month Follow-up (T2)

Secondary traumatic stress will be assessed using the Secondary Traumatic Stress Scale (STSS) (Guerra & Saiz, 2007). Scores at the final assessment will be compared with baseline scores to evaluate changes in secondary traumatic stress in the experimental and wait-list control groups.

Baseline (T0), Immediate Post-intervention (T1), 3-month Follow-up (T2)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Eva Maria León Zarceño, Universidad Miguel Hernández de Elche.
  • Principal Investigator: Vicente Alejandro March Luján, Catholic University of Valencia
  • Principal Investigator: Marie Laure Rodríguez-Quiroga, Universidad Miguel Hernández de Elche.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 21, 2026

Primary Completion (Estimated)

November 30, 2026

Study Completion (Estimated)

November 30, 2026

Study Registration Dates

First Submitted

November 3, 2026

First Submitted That Met QC Criteria

November 3, 2026

First Posted (Actual)

November 9, 2026

Study Record Updates

Last Update Posted (Actual)

November 9, 2026

Last Update Submitted That Met QC Criteria

November 3, 2026

Last Verified

November 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

De-identified individual participant data (IPD) underlying the primary and secondary outcomes will be made available to qualified researchers upon reasonable request submitted to the principal investigator. Data sharing will be subject to ethical review, a formal data-sharing agreement, and strict compliance with European Union GDPR regulations to safeguard minor participants' confidentiality.

IPD Sharing Time Frame

Data will become available after the primary manuscript publishing the final longitudinal findings is accepted

IPD Sharing Access Criteria

Individual participant data will not be publicly shared to protect minor participants' confidentiality in compliance with GDPR and local data protection regulations. Aggregate data and protocol materials are available upon request

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe